CGB-400

DRUG3 trials

Sponsors

CAGE Bio Inc.

Conditions

Rosacea

Phase 1

CGB-400 for the Reduction of Facial Redness

CompletedNCT04508660

CAGE Bio Inc.Rosacea

Start: 2018-10-26End: 2019-04-18Updated: 2020-08-11

CGB-400 for the Reduction of Facial Redness and Bumps and Blemishes

CompletedNCT04508205

CAGE Bio Inc.Rosacea

Start: 2018-10-26End: 2019-04-18Updated: 2020-08-12

Phase 2

CGB-400 Topical Gel for the Treatment of Inflammatory Lesions of Rosacea

CompletedNCT04886739

CAGE Bio Inc.Rosacea

Start: 2021-05-07End: 2021-12-22Updated: 2026-04-01